Development of labeled thymidine analogs for imaging tumor proliferation.

We have sought nucleoside analogs suitable for labeling with F-18 that could be used to image tumor proliferation with positron emission tomography (PET). The following three thymidine analogs were labeled with tritium and screened for their catabolism and biodistribution in vivo in mice: 5-fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl)uracil (FFUdR), 5-fluoro-1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-uracil (FFaraU) and 5-methyl-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl)uracil (FTdR). We found that all three compounds were stable to degradation in vivo and when incubated in blood. Of the three analogs tested, only FFUdR showed preferential retention in rapidly proliferating tissues, such as the spleen and implanted tumors, and it attained tissue to blood ratios of 2.1 at 2 h.

[1]  T. Borght,et al.  Brain tumor imaging with PET and 2-[carbon-11]thymidine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  H. Hayakawa,et al.  Diethylaminosulfur Trilfluoride (DAST) as a Fluorinating Agent of Pyrimidine Nucleosides Having a 2', 3'-Vicinal Diol System , 1990 .

[3]  J. F. Codington,et al.  Nucleosides. XVIII. Synthesis of 2'-Fluorothymidine, 2'-Fluorodeoxyuridine, and Other 2'-Halogeno-2'-Deoxy Nucleosides1,2 , 1964 .

[4]  L. Wiebe,et al.  Synthesis and tumor uptake of 5-halo-1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)[2-14C]uracils. , 1987, Journal of medicinal chemistry.

[5]  J Grierson,et al.  Utilization of labeled thymidine in DNA synthesis: studies for PET. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  K. Watanabe,et al.  Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. , 1979, Journal of medicinal chemistry.

[7]  T. Chou,et al.  Distribution, Metabolism, and Excretion of 1-(2-Fluoro-2-deoxy-β-d-arabinofuranosyl)thymine and 1-(2-Fluoro-2-deoxy-β-d-arabinofuranosyl)-5-iodocytosine , 1983 .

[8]  D. Santi,et al.  Mechanism of action of 2',5-difluoro-1-arabinosyluracil. , 1983, Journal of medicinal chemistry.

[9]  R. Quackenbush,et al.  Local Re‐Utilization of Thymidine In Normal Mouse Tissues As Measured With Iododeoxyuridine , 1988, Cell and tissue kinetics.

[10]  L G Strauss,et al.  The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  K. Ishiwata,et al.  Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  G. van Kaick,et al.  Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  P. Martiat,et al.  In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  A. Wolf,et al.  The synthesis of 18 F-5-fluorouracil. VII. , 1973, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.